Jump to content

Pipeline

Sign in to follow this  
Medikamente in Entwicklung

25 Einträge

  1. BTT-1023

    Indikation: Yes Phase: Yes
    • 0 comments
    • 2,190 views
  2. C15

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,641 views
  3. CM2489

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,592 views
  4. CPSI-2364

    Weiterer Name: Semapimod Indikation: Yes Phase: Yes
    • 0 comments
    • 1,620 views
  5. CT-P05

    Indikation: Yes Phase: No
    • 0 comments
    • 1,826 views
  6. CT-P17

    Indikation: Yes Phase: No
    • 0 comments
    • 2,152 views
  7. DPS-101

    Weiterer Name: Dermipsor Indikation: Yes Phase: Yes
    • 0 comments
    • 1,621 views
  8. GSK2586184

    Weiterer Name: früher: GLPG0778 Indikation: Yes Phase: Yes
    • 0 comments
    • 1,248 views
  9. HBP-348

    Weiterer Name: Hypericin Indikation: Yes Phase: Yes
    • 0 comments
    • 1,384 views
  10. IMO-3100

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,491 views
  11. INCB 18424

    Weiterer Name: Ruxolitinib Indikation: Yes Phase: Yes
    • 0 comments
    • 1,563 views
  12. MEDI-545

    Weiterer Name: MDX-1103 Indikation: Yes Phase: No
    • 0 comments
    • 1,249 views
  13. MT-1303

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,206 views
  14. MT203

    Weiterer Name: Namilumab Indikation: Yes Phase: No
    • 0 comments
    • 1,311 views
  15. P-3073

    Indikation: No Phase: Yes
    • 0 comments
    • 1,221 views
  16. PAP-1

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,155 views
  17. PH-10

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,242 views
  18. ProtoCure

    Indikation: Yes Phase: No
    • 0 comments
    • 1,078 views
  19. RhuDex

    Indikation: Yes Phase: No
    • 0 comments
    • 1,033 views
  20. Roflumilast dermal

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,226 views
  21. Rossoseq

    Indikation: Yes Phase: No
    • 0 comments
    • 1,342 views
  22. RTU-1096

    Indikation: No Phase: Yes
    • 0 comments
    • 992 views
  23. TA-650

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,397 views
  24. TRX4

    Weiterer Name: Otelixizumab Indikation: Yes Phase: No
    • 0 comments
    • 1,152 views
  25. VH

    Indikation: Yes Phase: No
    • 0 comments
    • 824 views
Sign in to follow this  
×